Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04628039 · ClinicalTrials.gov registry record
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 622
- Enrollment target
NCT04628039: Completed study, sponsored by VA Office of Research and Development.
NCT04628039 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 622 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04628039 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 622 participants
- Enrollment target
Study Summary
This is study is comprised of three approaches. First, the investigators will conduct a retrospective cohort study to determine factors associated with COVID-19 severity and complications and understand COVID-19 outcomes, including all-cause mortality, post-discharge events, and impacts of rehabilitation services (third aim). The second aim is a mixed-method study and follows COVID-19 patients with repeated surveys to determine patient-reported functional outcomes, health recovery, and rehabilitation needs after COVID-19. The investigators will recruit patients and their informal caregivers for interviews to assess their function and rehabilitation needs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 622 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04628039
The ClinicalTrials.gov registry entry for NCT04628039 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 622 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04628039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04628039 about?
NCT04628039 is a clinical study titled "Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs". This is study is comprised of three approaches. First, the investigators will conduct a retrospective cohort study to determine factors associated with COVID-19 severity and complications and understand COVID-19 outcomes, including all-cause mortality, post-discharge events, and impacts of rehabilit...
What is the current status of trial NCT04628039?
This trial is currently completed. The enrollment target is 622 participants. The study started on 2021-05-27. Estimated completion is 2025-12-31.
Who is sponsoring clinical trial NCT04628039?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.